Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Rating) traded down 1.4% during trading on Wednesday . The company traded as low as $24.91 and last traded at $25.03. 1,081 shares were traded during mid-day trading, a decline of 54% from the average session volume of 2,351 shares. The stock had previously closed at $25.38.
Virtus LifeSci Biotech Clinical Trials ETF Price Performance
The stock’s 50-day moving average price is $23.17 and its 200 day moving average price is $24.63.
About Virtus LifeSci Biotech Clinical Trials ETF
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
Read More
- Get a free copy of the StockNews.com research report on Virtus LifeSci Biotech Clinical Trials ETF (BBC)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.
